FDA approves first buprenorphine implant for treatment of opioid dependence
Wednesday, June 1, 2016 - 10:41
in Health & Medicine
The U.S. Food and Drug Administration today approved Probuphine, the first buprenorphine implant for the maintenance treatment of opioid dependence. Probuphine is designed to provide a constant, low-level dose of buprenorphine for six months in patients who are already stable on low-to-moderate doses of other forms of buprenorphine, as part of a complete treatment program. […]